Plasma Neurofilament Analysis in VITALITY-ALS

Time from ALS Symptom Onset to Key Disease Milestones for Slow, Intermediate, and Fast Progressors: a Real-World Cross-Sectional Survey

ENCALS Predictive Survival Model in FORTITUDE-ALS

Characterizing Hospitalization as an Outcome Measure in ALS Clinical Trials

Sudden Changes in the ALSFRS-R in Three ALS Clinical Trials

Grip Strength is More Than a Number: The Relationship Between Grip Strength and Fine Motor and Arm Function in FORTITUDE-ALS

IMPACT ALS EUROPE A European Survey of People Living with ALS

Update of COURAGE-ALS: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Efficacy and Safety of Reldesemtivin Patients with ALS

Relationship Between Quantitative Strength Changes and Functional Outcomes in the Phase 2 FORTITUDE-ALS Trial

Discovery of Reldesemtiv, a Fast Skeletal Muscle Troponin Activator for the Treatment of Impaired Muscle Function